CS-3003

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCS-3003
Drug Alias NameCS-3003CS3003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsSolid tumoursMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCstone Pharmaceuticals
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCstone Pharmaceuticals
Inactive CompaniesCstone Pharmaceutical (Shanghai) Co LtdCstone Pharmaceuticals (Suzhou) Co Ltd
Active IndicationsSolid tumoursMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A